Bath & Body Works stock saw a positive improvement to its Relative Strength (RS) Rating on Wednesday, rising from 79 to 83.
As you try to find the best stocks to buy and watch, be sure to pay attention to relative price strength.
This exclusive rating from Investor's Business Daily tracks price movement with a 1 (worst) to 99 (best) score. The rating shows how a stock's price performance over the trailing 52 weeks holds up against all the other stocks in our database.
Decades of market research shows that the market's biggest winners often have an RS Rating north of 80 in the early stages of their moves.
See How IBD Helps You Make More Money In Stocks
Is Bath & Body Works Stock A Buy?
Bath & Body Works stock has been rallying above its 200-day moving average since December and is not currently near a potential buy zone. See if the stock goes on to form a promising consolidation that could ignite a new run. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.
The home fragrance and body care product retailer reported negative growth for both sales and earnings last quarter. Bath & Body Works is expected to release its next quarterly numbers on or around Feb. 22.
Bath & Body Works stock earns the No. 16 rank among its peers in the Retail-Apparel/Shoes/Accessories industry group. Buckle and Foot Locker are also among the group's highest-rated stocks.
